Back to Agenda
Session 5 – Innovative Trial Design
Session Chair(s)
Dean Follmann, PhD
Assistant Director for Biostatistics; NIAID Chief Biostatistics Research Branch
National Institute of Allergy and Infectious Diseases, United States
Estelle Russek-Cohen, PhD
Senior Advisor, Office of Biostat
FDA, United States
Session 5 – Innovative Trial Design
Speaker(s)
Introduction to the Design and Analysis of SMARTs
Michael R. Kosorok, PhD
University of North Carolina At Chapel Hill, United States
W. R. Kenan, Jr. Distinguished Professor and Chair, Department of Biostatistics
A Modest Proposal
Michael Proschan, PhD
NIAID/NIH, United States
Mathematical Statistician
Optimal Tests of Treatment E ects for the Overall Population and Two Subpopulations in Randomized Trials, using Sparse Linear Programming
Michael Rosenblum, PhD
Johns Hopkins Bloomberg School of Public Health, United States
Professor, Biostatistics
Panelists
Qi Jiang, PhD
Amgen Inc., United States
Executive Director, Global Biostatistical Science
Robert J. Temple, MD
FDA, United States
Senior Advisor for Clinical Science, OCD and Immediate Office, OND, CDER
Have an account?